Article
Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Apr 2013
Rekhtman Natasha, Tafe Laura J, Chaft Jamie E, Wang Lu, Arcila Maria E, Colanta Agnes, Moreira Andre L, Zakowski Maureen F, Travis William D, Sima Camelia S, Kris Mark G, Ladanyi Marc
Abstract excerpt
Pulmonary large-cell carcinoma-a diagnostically and clinically controversial entity-is defined as a non-small-cell carcinoma lacking morphologic differentiation of either adenocarcinoma or squamous cell carcinoma, but suspected to represent an end stage of poor differentiation of these tumor types. Given the recent advances in immunohistochemistry to distinguish adenocarcinoma and squamous cell carcinoma, and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
